A weight and obesity care solution that delivers results
Explore how our comprehensive program addresses weight loss and cardiometabolic health, helping organizations control rising costs and demand for GLP-1 medications
Explore how our comprehensive program addresses weight loss and cardiometabolic health, helping organizations control rising costs and demand for GLP-1 medications
We’re so confident in our ability to help people achieve better health outcomes, we place our program fees at risk²
65% of participants lost weight at 1 year³. Modest weight loss can mean improvements to blood pressure, cholesterol and blood sugar⁴
Program participants who also engaged with our digital mental health program saw 13% greater weight loss⁵
The mounting popularity of GLP-1 medications is changing how organizations address obesity. In this webinar, the American Diabetes Association and Teladoc Health discuss the opportunities and costs of medication therapies for the long-term management of chronic conditions.
Gain insights, meet our members and learn more about our solutions in this curated collection of resources
Industry insight
Teladoc Health and leading employers discuss strategies for managing GLP-1 medications
Case study
Teladoc Health helped Ralph Lauren dramatically reduce the percentage of its employees classified as obese
My weight has come down because I think of the habits that I changed throughout the whole program.
Since starting the program, I definitely have more energy. I’m able to do more as far as moving around. I don’t feel so worn out all the time, so that’s been fantastic.
Teladoc Health helps me maintain my glucose numbers and my weight, because in the long run, it helps with my overall health. It just makes my life easier.
1. GLP-1s are available only where medically appropriate, as prescribed by an authorized healthcare provider, and where permitted under applicable state and federal law.
2. Full program fees at risk are available to commercial populations with at least 10 observable members. Outcomes for enrolled members who have been active for 6 months (engage with a connected device, complete a coaching session, share clinical data with the care team, or log-in to the participant portal) will be assessed in each annual measurement period. Measurement applies to the whole population using those who are observable. Credit will be applied to the entire population
3. Teladoc Health data, DS-12600
4. Blackburn G. (1995). Effect of degree of weight loss on health benefits. Obesity Research 3: 211S-216S. Reference for 10%: NIH, NHLBI Obesity Education Initiative. Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults. Available online here
5. Dzubur, Eldin. Long-term benefits of digital mental health program use during months of poor chronic disease management. 2023
The testimonials, opinions and statements reflect one individual's personal experience with Teladoc Health. Results and experiences may vary from person to person and will be unique to each individual. The testimonials are voluntarily provided and are not paid.
PL016020.A